Mice with experimental antiphospholipid syndrome display hippocampal dysfunction and a reduction of dendritic complexity in hippocampal CA1 neurones

Neuropathology and Applied Neurobiology

Volumn 41, Issue 5, 2015, Pages 657-671

  Frauenknecht, Katrin ^a   Katzav, Aviva ^c   Weiss Lavi, Ronen ^c   Sabag, Avishag ^c   Otten, Susanne ^a   Chapman, Joab ^c   Sommer, Clemens J ^a,b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b Focus Program Translational Neurosciences (FTN)   (Germany)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antiphospholipid syndrome; Behaviour; Dendrites; Dendritic spines; Golgi Cox method; Hippocampus; Synaptopodin

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN 2; MOLECULAR MARKER; PHOSPHOLIPID ANTIBODY; SYNAPTOBREVIN 2; SYNAPTOPODIN; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1;

ABNORMAL BEHAVIOR; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; BRAIN DYSFUNCTION; BRAIN INFARCTION; COGNITIVE DEFECT; CONTROLLED STUDY; DENDRITE; DENDRITIC SPINE; EXPERIMENTAL COGNITIVE TEST; FEMALE; GOLGI STAIN; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL DYSFUNCTION; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE CELL PLASTICITY; NISSL STAINING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT TERM MEMORY; STAIRCASE TEST; THROMBOSIS; Y-MAZE TEST; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CHEMICALLY INDUCED; DISEASE MODEL; MICROGLIA; MOTOR ACTIVITY; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; CA1 REGION, HIPPOCAMPAL; DENDRITIC SPINES; DISEASE MODELS, ANIMAL; FEMALE; MICE; MICE, INBRED BALB C; MICROGLIA; MOTOR ACTIVITY;

EID: 84949109106     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/nan.12180     Document Type: Article

References (46)

1. Giannakopoulos B, Krilis SA. The pathogenesis of the antiphospholipid syndrome. N Engl J Med 2013; 368: 1033-1044
2. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306
3. Schmidt R, Auer-Grumbach P, Fazekas F, Offenbacher H, Kapeller P. Anticardiolipin antibodies in normal subjects. Neuropsychological correlates and MRI findings. Stroke 1995; 26: 749-754
4. Shrot S, Katzav A, Korczyn AD, Litvinjuk Y, Hershenson R, Pick CG, Blank M, Zaech J, Shoenfeld Y, Sirota P, Chapman J. Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies. Lupus 2002; 11: 736-743
5. Frauenknecht K, Katzav A, Grimm C, Chapman J, Sommer CJ. Neurological impairment in experimental antiphospholipid syndrome is associated with increased ligand binding to hippocampal and cortical serotonergic 5-HT1A receptors. Immunobiology 2013; 218: 517-526
6. Menachem A, Chapman J, Katzav A. Significant changes in the levels of secreted cytokines in brains of experimental antiphospholipid syndrome mice. Autoimmune Dis 2012; 2012: 404815
7. Frauenknecht K, Katzav A, Grimm C, Chapman J, Sommer CJ. Altered receptor binding densities in experimental antiphospholipid syndrome despite only moderately enhanced autoantibody levels and absence of behavioral features. Immunobiology 2014; 219: 341-349
8. Lalonde R. The neurobiological basis of spontaneous alternation. Neurosci Biobehav Rev 2002; 26: 91-104
9. Mikolaenko I, Rao LM, Roberts RC, Kolb B, Jinnah HA. A Golgi study of neuronal architecture in a genetic mouse model for Lesch-Nyhan disease. Neurobiol Dis 2005; 20: 479-490
10. Ramakers GJ, Wolfer D, Rosenberger G, Kuchenbecker K, Kreienkamp HJ, Prange-Kiel J, Rune G, Richter K, Langnaese K, Masneuf S, Bösl MR, Fischer KD, Krugers HJ, Lipp HP, van Galen E, Kutsche K. Dysregulation of Rho GTPases in the αPix/Arhgef6 mouse model of X-linked intellectual disability is paralleled by impaired structural and synaptic plasticity and cognitive deficits. Hum Mol Genet 2012; 21: 268-286
11. Sheng C, Heng X, Zhang G, Xiong R, Li H, Zhang S, Chen S. DJ-1 deficiency perturbs microtubule dynamics and impairs striatal neurite outgrowth. Neurobiol Aging 2013; 34: 489-498
12. Bakimer R, Fishman P, Blank M, Sredni B, Djaldetti M, Shoenfeld Y. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J Clin Invest 1992; 89: 1558-1563
13. Simiand J, Keane PE, Morre M. The staircase test in mice: a simple and effi cient procedure for primary screening of anxiolytic agents. Psychopharmacology (Berl) 1984; 84: 48-53
14. Pick CG, Peter Y, Terkel J, Gavish M, Weizman R. Effect of the neuroactive steroid alpha-THDOC on staircase test behavior in mice. Psychopharmacology (Berl) 1996; 128: 61-66
15. Dellu F, Mayo W, Cherkaoui J, Le Moal M, Simon H. A two-trial memory task with automated recording: study in young and aged rats. Brain Res 1992; 588: 132-139
16. Gibb R, Kolb B. A method for vibratome sectioning of Golgi-Cox stained whole rat brain. J Neurosci Methods 1998; 79: 1-4
17. Sholl DA. Dendritic organization in the neurons of the visual and motor cortices of the cat. J Anat 1953; 87: 387-406
18. Frauenknecht K, Bargiotas P, Bauer H, von Landenberg P, Schwaninger M, Sommer C. Neuroprotective effect of Fn14 deficiency is associated with induction of the granulocyte-colony stimulating factor (G-CSF) pathway in experimental stroke and enhanced by a pathogenic human antiphospholipid antibody. J Neuroimmunol 2010; 227: 1-9
19. Paxinos G, Franklin KJB. The Mouse Brain in Stereotaxic Coordinates, 2nd edn, San Diego, CA/London: Academic, 2001
20. Katzav A, Grigoriadis NC, Ebert T, Touloumi O, Blank M, Pick CG, Shoenfeld Y, Chapman J. Coagulopathy triggered autoimmunity: experimental antiphospholipid syndrome in factor V Leiden mice. BMC Med 2013; 11: 92
21. Sousa N, Lukoyanov NV, Madeira MD, Almeida OFX, Paula-Barbosa MM. Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement. Neuroscience 2000; 97: 253-266
22. Martínez-Téllez RI, Hernández-Torres E, Gamboa C, Flores G. Prenatal stress alters spine density and dendritic length of nucleus accumbens and hippocampus neurons in rat offspring. Synapse 2009; 63: 794-804
23. Rubino T, Realini N, Braida D, Guidi S, Capurro V, Viganò D, Guidali C, Pinter M, Sala M, Bartesaghi R, Parolaro D. Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood. Hippocampus 2009; 19: 763-772
24. Vila-Luna S, Cabrera-Isidoro S, Vila-Luna L, Juárez-Díaz I, Bata-García JL, Alvarez-Cervera FJ, Zapata-Vázquez RE, Arankowsky-Sandoval G, Heredia-López F, Flores G, Góngora-Alfaro JL. Chronic caffeine consumption prevents cognitive decline from young to middle age in rats, and is associated with increased length, branching, and spine density of basal dendrites in CA1 hippocampal neurons. Neuroscience 2012; 202: 384-395
25. Tucker RP. The roles of microtubule-associated proteins in brain morphogenesis: a review. Brain Res Rev 1990; 15: 101-120
26. Kitagawa K, Matsumoto M, Niinobe M, Mikoshiba K, Hata R, Ueda H, Handa N, Fukunaga R, Isaka Y, Kimura K, Kamada T. Microtubule-associated protein 2 as a sensitive marker for cerebral ischemic damage: immunohistochemical investigation of dendritic damage. Neuroscience 1989; 31: 401-411
27. Matesic DF, Lin RCS. Microtubule-associated protein 2 as an early indicator of ischemia-induced neurodegeneration in the gerbil forebrain. J Neurochem 1994; 63: 1012-1020
28. Söllner T, Whiteheart SW, Brunner M, Erdjument-Bromage H, Geromanos S, Tempst P, Rothman JE. SNAP receptors implicated in vesicle targeting and fusion. Nature 1993; 362: 318-324
29. Hinz B, Becher A, Mitter D, Schulze K, Heinemann U, Draguhn A, Ahnert-Hilger G. Activity-dependent changes of the presynaptic synaptophysin-synaptobrevin complex in adult rat brain. Eur J Cell Biol 2001; 80: 615-619
30. Levav T, Wirthaim O, Weiss R, Grossmann Y, Golan H. Impaired synaptogenesis and long-term modulation of behavior following postnatal elevation of GABA levels in mice. Neuropharmacology 2008; 54: 387-398
31. Deller T, Merten T, Roth SU, Mundel P, Frotscher M. Actinassociated protein synaptopodin in the rat hippocampal formation: localization in the spine neck and close association with the spine apparatus of principal neurons. J Comp Neurol 2000; 418: 164-181
32. Deller T, Korte M, Chabanis S, Drakew A, Schwegler H, Stefani GG, Zuniga A, Schwarz K, Bonhoeffer T, Zeller R, Frotscher M, Mundel P. Synaptopodin-deficient mice lack a spine apparatus and show deficits in synaptic plasticity. Proc Natl Acad Sci U S A 2003; 100: 10494-10499
33. Vlachos A, Korkotian E, Schonfeld E, Copanaki E, Deller T, Segal M. Synaptopodin regulates plasticity of dendritic spines in hippocampal neurons. J Neurosci 2009; 29: 1017-1033
34. Tanne D, Katzav A, Beilin O, Grigoriadis NC, Blank M, Pick CG, Landenberg PV, Shoenfeld Y, Chapman J. Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome. Neurobiol Dis 2008; 30: 56-64
35. Caronti B, Pittoni V, Palladini G, Valesini G. Anti-beta 2-glycoprotein I antibodies bind to central nervous system. J Neurol Sci 1998; 156: 211-219
36. Chapman J, Cohen-Armon M, Shoenfeld Y, Korczyn AD. Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus 1999; 8: 127-133
37. Dale RC, Yin K, Ding A, Merheb V, Varadkhar S, McKay D, Singh-Grewal D, Brilot F. Antibody binding to neuronal surface in movement disorders associated with lupus and antiphospholipid antibodies. Dev Med Child Neurol 2011; 53: 522-528
38. Shoenfeld Y, Nahum A, Korczyn AD, Dano M, Rabinowitz R, Beilin O, Pick CG, Leider-Trejo L, Kalashnikova L, Blank M, Chapman J. Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus 2003; 12: 436-442
39. Goshen I, Kreisel T, Ounallah-Saad H, Renbaum P, Zalzstein Y, Ben-Hur T, Levy-Lahad E, Yirmiya R. A dual role for interleukin-1 in hippocampal-dependent memory processes. Psychoneuroendocrinology 2007; 32: 1106-1115
40. del Rey A, Balschun D, Wetzel W, Randolf A, Besedovsky HO. A cytokine network involving brain-borne IL-1β, IL-1ra, IL-18, IL-6, and TNFα operates during long-term potentiation and learning. Brain Behav Immun 2013; 33: 15-23
41. Gilmore JH, Fredrik Jarskog L, Vadlamudi S, Lauder JM. Prenatal infection and risk for schizophrenia: IL-1beta, IL-6, and TNFalpha inhibit cortical neuron dendrite development. Neuropsychopharmacology 2004; 29: 1221-1229
42. Neumann H, Schweigreiter R, Yamashita T, Rosenkranz K, Wekerle H, Barde YA. Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a rho-dependent mechanism. J Neurosci 2002; 22: 854-862
43. Kim IJ, Beck HN, Lein PJ, Higgins D. Interferon gamma induces retrograde dendritic retraction and inhibits synapse formation. J Neurosci 2002; 22: 4530-4539
44. Richwine AF, Sparkman NL, Dilger RN, Buchanan JB, Johnson RW. Cognitive deficits in interleukin-10-deficient mice after peripheral injection of lipopolysaccharide. Brain Behav Immun 2009; 23: 794-802
45. Ziporen L, Polak-Charcon S, Korczyn DA, Goldberg I, Afek A, Kopolovic J, Chapman J, Shoenfeld Y. Neurological dysfunction associated with antiphospholipid syndrome: histopathological brain findings of thrombotic changes in a mouse model. Clin Dev Immunol 2004; 11: 67-75
46. Raschi E, Testoni C, Bosisio D, Borghi MO, Koike T, Mantovani A, Meroni PL. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood 2003; 101: 3495-3500